CTOs on the Move

The Callos Companies

www.callos.com

 
The Callos Companies is a Youngstown, OH-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.callos.com
  • 5083 Market St
    Youngstown, OH USA 44512
  • Phone: 330.788.4001

Executives

Name Title Contact Details

Similar Companies

Alfa Tech Consulting Group

Alfa Tech Consulting Group is a San Jose, CA-based company in the Business Services sector.

G-Research

G-Research is a leading quantitative research and technology firm, with offices in London and Dallas. We hire the brightest minds in the world to tackle some of the biggest questions in finance. We pair this expertise with machine learning, big data, and some of the most advanced technology available to predict movements in financial markets. We take pride in our dynamic, flexible and highly stimulating culture where world-beating ideas are prized and rewarded. We employ some of the best people in their field and are keen to nurture their talent in a supportive working environment. 

Harris Marketing Group / Clearwing

Harris Marketing Group / Clearwing is a Wales, WI-based company in the Business Services sector.

California Optical Corporation

California Optical Corporation is a San Leandro, CA-based company in the Business Services sector.

Vansen Pharma, Inc.

Vansen Pharma Inc. is a specialty pharmaceutical company focused on broad therapeutic areas that are anticipated to grow and present an opportunity for major expansion.  Vansen will expand its commercial presence by adding complimentary products through in-licensing, co-promotion and acquisitions, resulting in a comprehensive product portfolio.  With its US based sales force, Vansen can better serve the increasing healthcare needs of patients and enhance growth.  Vansen's current product portfolio of anti-infectives, including Factive®, Spectracef® and Cefditoren Pivoxil®, provides a strong and stable revenue base from which to grow and expand our company. Our experienced management team is aggressively pursuing acquisitions of accretive specialty products, including legacy drugs and cash flow positive healthcare companies.  We look forward to executing our growth strategy and creating lasting shareholder value for our investors.